NO984197D0 - Fremgangsmåte for behandling av autisme - Google Patents
Fremgangsmåte for behandling av autismeInfo
- Publication number
- NO984197D0 NO984197D0 NO984197A NO984197A NO984197D0 NO 984197 D0 NO984197 D0 NO 984197D0 NO 984197 A NO984197 A NO 984197A NO 984197 A NO984197 A NO 984197A NO 984197 D0 NO984197 D0 NO 984197D0
- Authority
- NO
- Norway
- Prior art keywords
- procedures
- treating autism
- treating
- autism
- olanzapine
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
- A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Landscapes
- Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Psychiatry (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Hospice & Palliative Care (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Chemical Treatment Of Metals (AREA)
- Separation Using Semi-Permeable Membranes (AREA)
- Luminescent Compositions (AREA)
- Control Of Motors That Do Not Use Commutators (AREA)
- Transplanting Machines (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US1316296P | 1996-03-11 | 1996-03-11 | |
PCT/US1996/019576 WO1997033585A1 (en) | 1996-03-11 | 1996-12-04 | Method for treating autism |
Publications (2)
Publication Number | Publication Date |
---|---|
NO984197D0 true NO984197D0 (no) | 1998-09-11 |
NO984197L NO984197L (no) | 1998-11-03 |
Family
ID=21758619
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO984197A NO984197L (no) | 1996-03-11 | 1998-09-11 | FremgangsmÕte for behandling av autisme |
Country Status (19)
Country | Link |
---|---|
EP (1) | EP0946179B1 (no) |
JP (1) | JP2000506860A (no) |
KR (1) | KR19990087715A (no) |
CN (1) | CN1213970A (no) |
AT (1) | ATE249832T1 (no) |
AU (1) | AU709181B2 (no) |
BR (1) | BR9612552A (no) |
CA (1) | CA2248741A1 (no) |
CZ (1) | CZ290498A3 (no) |
DE (1) | DE69630055T2 (no) |
EA (1) | EA000768B1 (no) |
ES (1) | ES2206614T3 (no) |
HU (1) | HUP9903688A3 (no) |
IL (1) | IL126161A0 (no) |
NO (1) | NO984197L (no) |
NZ (1) | NZ324615A (no) |
PL (1) | PL328948A1 (no) |
TR (1) | TR199801798T2 (no) |
WO (1) | WO1997033585A1 (no) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6348455B1 (en) | 1998-11-23 | 2002-02-19 | Sepracor Inc. | Desmetylolanzapine compositions and methods |
CA2352611A1 (en) | 1998-11-23 | 2000-06-02 | Sepracor Inc. | 2-hydroxymethylolanzapine compositions and methods |
AU757870B2 (en) * | 1998-11-23 | 2003-03-06 | Sepracor, Inc. | Pharmaceutical compositions containing olanzapine-N-oxide |
AU2013293167B2 (en) | 2012-07-22 | 2019-04-18 | Indiana University Research And Technology Corporation | Modulation sAPP, sAPP alpha and BDNF levels in individuals diagnosed with FXS and ASD |
DK3058371T3 (da) | 2013-10-14 | 2021-08-02 | Univ Indiana Res & Tech Corp | Anvendelse af acamprosat til at modulere erk-1-2-aktivering i dyremodeller til fxs og asd og individer diagnosticeret med fxs og asd |
RU2666598C1 (ru) * | 2017-07-14 | 2018-09-11 | Федеральное государственное бюджетное научное учреждение "Научно-исследовательский институт фармакологии имени В.В. Закусова" | Средство для коррекции расстройств аутистического спектра |
KR102285577B1 (ko) | 2020-11-11 | 2021-08-04 | 김의철 | 자폐를 가진 유소년의 무약물 치료방법 및 시스템 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5225407A (en) * | 1990-02-22 | 1993-07-06 | Glaxo Group Limited | 5-HT3 receptor antagonists for the treatment of autism |
US5229382A (en) * | 1990-04-25 | 1993-07-20 | Lilly Industries Limited | 2-methyl-thieno-benzodiazepine |
US5457101A (en) * | 1994-06-03 | 1995-10-10 | Eli Lilly And Company | Thieno[1,5]benzoidiazepine use |
-
1996
- 1996-12-04 CN CN96180207A patent/CN1213970A/zh active Pending
- 1996-12-04 WO PCT/US1996/019576 patent/WO1997033585A1/en active IP Right Grant
- 1996-12-04 JP JP09532571A patent/JP2000506860A/ja not_active Withdrawn
- 1996-12-04 EP EP96942934A patent/EP0946179B1/en not_active Expired - Lifetime
- 1996-12-04 PL PL96328948A patent/PL328948A1/xx unknown
- 1996-12-04 BR BR9612552A patent/BR9612552A/pt not_active Application Discontinuation
- 1996-12-04 KR KR1019980707182A patent/KR19990087715A/ko not_active Application Discontinuation
- 1996-12-04 ES ES96942934T patent/ES2206614T3/es not_active Expired - Lifetime
- 1996-12-04 IL IL12616196A patent/IL126161A0/xx unknown
- 1996-12-04 HU HU9903688A patent/HUP9903688A3/hu unknown
- 1996-12-04 CZ CZ982904A patent/CZ290498A3/cs unknown
- 1996-12-04 AT AT96942934T patent/ATE249832T1/de not_active IP Right Cessation
- 1996-12-04 EA EA199800821A patent/EA000768B1/ru not_active IP Right Cessation
- 1996-12-04 TR TR1998/01798T patent/TR199801798T2/xx unknown
- 1996-12-04 NZ NZ324615A patent/NZ324615A/xx unknown
- 1996-12-04 DE DE69630055T patent/DE69630055T2/de not_active Expired - Fee Related
- 1996-12-04 AU AU11501/97A patent/AU709181B2/en not_active Ceased
- 1996-12-04 CA CA002248741A patent/CA2248741A1/en not_active Abandoned
-
1998
- 1998-09-11 NO NO984197A patent/NO984197L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
ES2206614T3 (es) | 2004-05-16 |
CA2248741A1 (en) | 1997-09-18 |
DE69630055D1 (de) | 2003-10-23 |
EA199800821A1 (ru) | 1999-02-25 |
HUP9903688A3 (en) | 2001-12-28 |
ATE249832T1 (de) | 2003-10-15 |
NO984197L (no) | 1998-11-03 |
BR9612552A (pt) | 1999-07-20 |
AU1150197A (en) | 1997-10-01 |
DE69630055T2 (de) | 2004-06-03 |
EP0946179A1 (en) | 1999-10-06 |
PL328948A1 (en) | 1999-03-01 |
TR199801798T2 (xx) | 1998-12-21 |
NZ324615A (en) | 2000-08-25 |
EP0946179B1 (en) | 2003-09-17 |
CN1213970A (zh) | 1999-04-14 |
AU709181B2 (en) | 1999-08-26 |
EA000768B1 (ru) | 2000-04-24 |
WO1997033585A1 (en) | 1997-09-18 |
CZ290498A3 (cs) | 1999-10-13 |
EP0946179A4 (en) | 2000-04-19 |
HUP9903688A2 (hu) | 2000-03-28 |
KR19990087715A (ko) | 1999-12-27 |
IL126161A0 (en) | 1999-05-09 |
JP2000506860A (ja) | 2000-06-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE241351T1 (de) | Isobutylgaba und dessen derivate zur schmerzbehandlung | |
EA200100572A1 (ru) | Способ применения ингибитора циклооксигеназы-2 и одного или нескольких противоопухолевых лекарственных средств в качестве комбинированного способа лечебного воздействия при лечении неоплазии | |
PT880350E (pt) | Tratamento de esclerose multipla | |
ATE181422T1 (de) | Verfahren zur diagnose von praeklampsie | |
NO975234D0 (no) | Fremgangsmåte for behandling av maniske og bipolare forstyrrelser | |
DE69711078D1 (de) | Topische verwendung von kappa-opioidrezeptoragonisten zur behandlung von augenschmerz | |
SE9603725D0 (sv) | New teatment | |
BR9809678A (pt) | Derivados de triptolìdeo úteis no tratamento de doenças autoimunes | |
NO984197D0 (no) | Fremgangsmåte for behandling av autisme | |
FI973185A (fi) | Melatoniinin käyttö lääkeriippuvuudesta kärsivien potilaiden hoitoon | |
NO984196L (no) | FremgangsmÕte for behandling av stoffmisbruk | |
NO984198L (no) | FremgangsmÕte for behandling av aggresjon | |
EA199800818A1 (ru) | Способ лечения бессонницы | |
UA31502A (uk) | Спосіб визначення індивідуальної чутливості онкохворого до спеціального протипухлинного лікування | |
NO984964L (no) | Anvendelse av fosfonsyreestere for behandling av funksjonelle forstyrrelser i hjernen og ved depresjon | |
BA95039A (bs) | Set za prevenciju i terapiju bolne menstruacije | |
UA7951A (uk) | Спосіб сочетаної вакуум-лазерної терапії | |
UA27148C2 (uk) | Спосіб лікуваhhя гострого пієлоhефриту | |
DE29504377U1 (de) | Autoinjector zur Behandlung der akuten respiratorischen Insuffizienz |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |